Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$5.07 - $8.44 $593 - $987
-117 Reduced 39.93%
176 $0
Q2 2023

Aug 14, 2023

BUY
$6.19 - $8.78 $414 - $588
67 Added 29.65%
293 $1,000
Q1 2023

May 08, 2023

BUY
$7.8 - $10.11 $850 - $1,101
109 Added 93.16%
226 $2,000
Q4 2022

Feb 14, 2023

BUY
$6.26 - $9.34 $732 - $1,092
117 New
117 $0

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.